<body><a name="drugname"></a><table class="topbox" width="100%">
<tr>
<td><span class="topboxgenname">ACITRETIN</span><br/>(a-ci-tree'tin)<br/><span class="topboxtradename">Soriatane<br/></span><b>Classifications:</b> <span class="classification">skin and mucous membrane agent</span>; <span class="classification">antiacne</span>; <span class="classification">retinoid</span><br/><b>Prototype: </b>Isotretinoin<br/><b>Pregnancy Category: </b>X<br/></td>
</tr>
</table>
<h1><a name="avail">Availability</a></h1>
<p>10 mg, 25 mg capsules</p>
<h1><a name="action">Actions</a></h1>
<p>The mechanism of action of acitretin is unknown.</p>
<h1><a name="therapef">Therapeutic Effects</a></h1>
<p>Acitretin is a highly toxic metabolite of retinol (vitamin A).</p>
<h1><a name="uses">Uses</a></h1>
<p>Treatment of severe psoriasis in adults.</p>
<h1><a name="contrain">Contraindications</a></h1>
<p>Pregnancy (category X), sensitivity to parabens, lactation.</p>
<h1><a name="precaution">Cautious Use</a></h1>
<p>Patients with impaired hepatic function, hepatitis, diabetes mellitus, obesity, alcoholism, history of pancreatitis, hypertriglyceridemia,
         hypercholesterolemia, coronary artery disease, retinal disease, degenerative joint disease.
      </p>
<h1><a name="rtedsg">Route &amp; Dosage</a></h1>
<table cellpadding="4" cellspacing="0" class="rdbox" width="100%">
<tr>
<td><span class="indicationtitle">Psoriasis</span><br/><span class="rdage">Adult:</span> <span class="rdroute">PO</span> 2550 mg q.d. with main meal<br/></td>
</tr>
</table>
<h1><a name="admintn">Administration</a></h1><span class="adminroutetype">Oral</span><br/><ul>
<li>Administer as single dose with main meal because food enhances absorption.</li>
<li>Store at 15°25° C (59°77° F) and protect from light. After opening, avoid exposure to high
            temperatures and humidity.
         </li>
</ul>
<h1><a name="adverse">Adverse Effects (<img src="../images/special/greaterorequal.gif"/>1%)</a></h1><span class="typehead">Body as a Whole:</span>
<span class="speceff-common">Hyperesthesia, paresthesias, arthralgia, progression of existing spinal hyperostosis, rigors,</span> back pain, hypertonia, myalgia, fatigue, hot flashes, increased appetite. <span class="typehead">CNS:</span> Headache, depression, aggressive feelings and thoughts of self-harm, insomnia, somnolence. <span class="typehead">CV:</span> Flushing, edema. <span class="typehead">GI:</span>
<span class="speceff-common">Dry mouth, increased liver function tests, increased triglycerides and cholesterol,</span> hepatitis, gingival bleeding, gingivitis, increased saliva, stomatitis, thirst, ulcerative stomatitis, abdominal pain, diarrhea,
      nausea, tongue disorder. <span class="typehead">Special Senses:</span> Blurred vision, blepharitis, conjunctivitis, decreased night vision/night blindness, eye pain, photophobia; earache, tinnitus;
      taste perversion. <span class="typehead">Respiratory:</span>  Sinusitis. <span class="typehead">Skin:</span>
<span class="speceff-common">Alopecia, skin peeling, dry skin, nail disorders, pruritus, rash, cheilitis, skin atrophy, paronychia,</span> abnormal skin odor and hair texture, cold/clammy skin, increased sweating, purpura, seborrhea, skin ulceration, sunburn. <span class="typehead">Other:</span>
<span class="speceff-common">Rhinitis, epistaxis, xerophthalmia</span>. 
      <h1><a name="interactions">Interactions</a></h1><span class="typehead"> Drug:</span>  Combination with <b>ethanol</b> can create <b>etretinate,</b> which has a significantly longer half-life than acitretin; interferes with the contraceptive efficacy of <b>progestin</b>-only <span class="classification">oral contraceptives</span>.  <span class="typehead">Food:</span> Avoid excess vitamin A. 
      <h1><a name="pharmaks">Pharmacokinetics</a></h1><span class="typehead">Absorption:</span> Rapidly absorbed from GI tract, optimal absorption when taken with food. <span class="typehead">Peak:</span> 25 h. <span class="typehead">Distribution:</span> Crosses placenta, distributed into breast milk. <span class="typehead">Metabolism:</span> Metabolized active metabolite, <i>cis</i>-acitretin. <span class="typehead">Elimination:</span>  Excreted in both urine and feces. <span class="typehead">Half-Life:</span> 49 h acitretin, 63 h <i>cis</i>-acitretin. 
      <h1><a name="nursing"><span class="implictitle">Nursing Implications</span></a></h1>
<p><span class="adeffecttitle">Assessment &amp; Drug Effects</span></p>
<ul>
<li>Monitor for S&amp;S of pancreatitis or loss of glycemic control in diabetics. Report either condition immediately to physician.</li>
<li>Lab tests: Before initiating therapy and at 1- to 2-wk intervals until response to drug is known, do lipid profile and liver
            function tests. Monitor blood glucose and HbA<sub>1-C</sub> periodically.
         </li>
</ul>
<p><span class="eductitle">Patient &amp; Family Education</span></p>
<ul>
<li>
            							Note: Transient worsening of psoriasis may occur during early therapy.
            						
         </li>
<li>Review common adverse effects of drug; lag time of 23 mo may be necessary before drug effect is evident.</li>
<li>Discontinue drug and report immediately to physician if visual problems develop.</li>
<li>
            							Note: Dry eyes with decreased tolerance for contact lenses may occur.
            						
         </li>
<li>Do not drink alcohol while taking this drug; it increases risk of hepatotoxicity and hypertriglyceridemia; females should
            avoid alcohol during and for 2 mo following therapy.
         </li>
<li>Do not donate blood for 3 y following therapy.</li>
<li>Avoid excessive exposure to sunlight or UV light.</li>
<li>Use two forms of effective contraception for 1 mo before and at least 3 y following therapy because of the serious risk of
            fetal deformities that could result from exposure to this medication.
         </li>
<li>Do not breast feed while taking this drug</li>
</ul>
<hr/>
<p><span class="footer">Common adverse effects in <i>italic</i>, life-threatening effects <u>underlined</u>; generic names in <b>bold</b>; classifications in <small>SMALL CAPS</small>; <img border="0" src="../images/maple.gif"/> Canadian drug name; <img border="0" src="../images/pr.gif"/> Prototype drug</span></p>
</body>